Letter by Al-Atassi et al Regarding Article, "Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial"

被引：0
|
作者：
Al-Atassi, Talal [1 ]
Rodriguez, Maria Lorena [1 ]
Ruel, Marc [1 ,2 ]
机构：
[1] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON, Canada
[2] Univ Ottawa, Inst Heart, Dept Epidemiol & Community Med, Ottawa, ON, Canada
来源：
CIRCULATION | 2015年 / 132卷 / 01期
关键词：
SEATTLE ANGINA QUESTIONNAIRE;
D O I：
10.1161/CIRCULATIONAHA.114.014001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e10 / e10
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
    Cohen, David J.
    Osnabrugge, Ruben L.
    Magnuson, Elizabeth A.
    Wang, Kaijun
    Li, Haiyan
    Chinnakondepalli, Khaja
    Pinto, Duane
    Abdallah, Mouin S.
    Vilain, Katherine A.
    Morice, Marie-Claude
    Dawkins, Keith D.
    Kappetein, A. Pieter
    Mohr, Friedrich W.
    Serruys, Patrick W.
    CIRCULATION, 2014, 130 (14) : 1146 - 1157
  • [2] Letter by Uretsky Regarding Article, "Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial"
    Uretsky, Barry F.
    CIRCULATION, 2011, 123 (13) : E398 - E398
  • [3] Response to Letter Regarding Article, "Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial"
    Morice, Marie-Claude
    CIRCULATION, 2011, 123 (13) : E399 - E399
  • [4] Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease
    Lee, MS
    Kapoor, N
    Jamal, F
    Czer, L
    Aragon, J
    Forrester, J
    Kar, S
    Dohad, S
    Kass, R
    Eigler, N
    Trento, A
    Shah, PK
    Makkar, RR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 864 - 870
  • [5] Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease
    Sunagawa, Gengo
    Komiya, Tatsuhiko
    Tamura, Nobushige
    Kobayashi, Taira
    Furukawa, Tomokuni
    Matsushita, Akihito
    Murashita, Takashi
    Kanno, Kazuyoshi
    Hayashi, Sachiko
    Watanabe, Shun
    Sakaguchi, Genichi
    CIRCULATION, 2007, 116 (16) : 394 - 395
  • [6] Comparison of percutaneous coronary intervention with drug-eluting stents with coronary artery bypass surgery for unprotected left main coronary artery disease
    Lee, MS
    Kapoor, M
    Jamal, F
    Czer, L
    Aragon, J
    Forrester, J
    Kar, S
    Dohad, S
    Kass, R
    Eigler, N
    Trento, A
    Shah, PK
    Makkar, R
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 201H - 201H
  • [7] Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease
    Germing, A
    MEDIZINISCHE KLINIK, 2006, 101 (05) : 426 - 427
  • [8] Coronary artery bypass surgery might be superior to percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease
    Sunagawa, Genoo
    Komiya, Tastuhiko
    Tamura, Nobushige
    Sakaguchi, Genichi
    Kobayashi, Taira
    Nakamura, Hiromasa
    Furukawa, Tomokuni
    Matsushita, Akihito
    Murashita, Takashi
    Watanabe, Shun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 207A - 207A
  • [9] Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
    Morice, Marie-Claude
    Serruys, Patrick W.
    Kappetein, A. Pieter
    Feldman, Ted E.
    Stahle, Elisabeth
    Colombo, Antonio
    Mack, Michael J.
    Holmes, David R.
    Torracca, Lucia
    van Es, Gerrit-Anne
    Leadley, Katrin
    Dawkins, Keith D.
    Mohr, Friedrich
    CIRCULATION, 2010, 121 (24) : 2645 - 2653
  • [10] Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial
    Cohen, David J.
    Lavelle, Tara A.
    Van Hout, Ben
    Li, Haiyan
    Lei, Yang
    Robertus, Katherine
    Pinto, Duane
    Magnuson, Elizabeth A.
    Mcgarry, Thomas F.
    Lucas, Scott K.
    Horwitz, Phillip A.
    Henry, Carl A.
    Serruys, Patrick W.
    Mohr, Friedrich W.
    Kappetein, A. Pieter
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 198 - 209
12345